Literature DB >> 6416500

The incidental malignant melanoma.

R H Griffiths, J C Briggs.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6416500      PMCID： PMC1549956          DOI： 10.1136/bmj.287.6404.1552

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  6 in total

1.  Prognostic significance of the histological features of malignant melanoma.

Authors:  V J McGovern; H M Shaw; G W Milton; G A Farago
Journal:  Histopathology       Date:  1979-09       Impact factor: 5.087

2.  Effect of anatomical location on prognosis in patients with clinical stage I melanoma.

Authors:  G S Rogers; A W Kopf; D S Rigel; R J Friedman; J L Levine; M Levenstein; R S Bart; M M Mintzis
Journal:  Arch Dermatol       Date:  1983-08

3.  Prognostic value of tumour thickness in cutaneous malignant melanoma.

Authors:  I Jeffrey; P Royston; C Sowter; G Slavin; A Price; A Pomerance; S Goolamali; D Pinto
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

4.  A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.

Authors:  C M Balch; T M Murad; S J Soong; A L Ingalls; N B Halpern; W A Maddox
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

5.  A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models.

Authors:  C L Day; R A Lew; M C Mihm; A J Sober; M N Harris; A W Kopf; T B Fitzpatrick; T J Harrist; F M Golomb; A Postel; P Hennessey; S L Gumport; J W Raker; R A Malt; A B Cosimi; W C Wood; D F Roses; F Gorstein; D Rigel; R J Friedman; M M Mintzis; R W Grier
Journal:  Ann Surg       Date:  1982-01       Impact factor: 12.969

6.  Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity?

Authors:  V J McGovern; H M Shaw; G W Milton; G A Farago
Journal:  Histopathology       Date:  1980-05       Impact factor: 5.087
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.